Breast cancer axillary lymph node metastasis detection by a high-resolution dedicated breast camera: A comparative study with SPECT and pinhole SPECT

Cancer Biotherapy and Radiopharmaceuticals

Volumn 22, Issue 6, 2007, Pages 799-811

  Spanu, Angela ^a   Chessa, Francesca ^a   Sanna, Daniela ^a   Cottu, Pierina ^a   Manca, Alessandra ^a   Nuvoli, Susanna ^a   Madeddu, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

99mTc tetrofosmin; Axillary lymph node metastases; Breast cancer; Dedicated breast camera; Pinhole SPECT; SPECT

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; HIGH RESOLUTION DEDICATED BREAST CAMERA; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; OUTCOME ASSESSMENT; PINHOLE SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GAMMA CAMERAS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 37549022215     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.367     Document Type: Article

References (36)

1. Schillaci O, Buscombe JR. Breast scintigraphy today: Indications and limitations. Eur J Nucl Med Mol Imaging 2004;31(Suppl. 1):S35.
2. 99mTc-MIBI in the detection of axillary lymph node metastases of breast carcinoma. Acta Radiol 1999;40:491.
3. Ortapamuk H, Ozmen MM, Ibis S, et al. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: A comparative study with mammography and histopathology. Eur J Surg 1999;165:1147.
4. Jaukovic LDj, Ajdinovic BZ, Jankovic ZD, et al. Technetium-99-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement. Nucl Med Rev Cent East Eur 2006;9:30.
5. 99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis. Eur J Nucl Med 2001;28:1781.
6. Schillaci O, Scopinaro F, Spanu A. Detection of axillary lymph node metastases in breast cancer with Tc-99m tetrofosmin scintigraphy. Int J Oncol 2002;20:483.
7. 99mTc- tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2000;15:81.
8. Spanu A, Tanda F, Dettori G, et al. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer nonpalpable axillary lymph node metastases detection. Q J Nucl Med 2003;47:116.
9. Scopinaro F, Pani R, De Vincentis G, et al. High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: Use of a new dedicated gamma camera. Eur J Nucl Med 1999;26:1279.
10. Brem RF, Schoonjans JM, Kieper DA, et al. High-resolution scintimammography: A pilot study. J Nucl Med 2002;43:909.
11. Coover LR, Caravaglia G, Kuhn P. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J Nucl Med 2004;45:553.
12. Rhodes DJ, O'Connor MK, Phillips SW, et al. Molecular breast imaging: A new technique using technetium Tc-99m scintimammography to detect small tumors of the breast. Mayo Clin Proc 2005;80:24.
13. Spanu A, Dettori G, Chessa F, et al. The usefulness of planar scintimammography with dedicated breast camera and SPECT in primary breast cancer detection. Q J Nucl Med Mol Imaging 2006;50(Suppl. 1):162.
14. Chiaramida P, Spanu A, Madeddu G. 180° Pinhole (P) SPECT and 360° (C) SPECT spatial resolution: An experimental model. Q J Nucl Med 1998;42(Suppl. 1):11.
15. Manglos SH, Jaszezak RJ, Greer KL. Cone beam SPECT reconstruction with camera tilt. Phys Med Biol 1989;34:625.
16. Green FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual, 6th ed. New York: Springer, 2002.
17. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181.
18. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer 1983;52:1551.
19. Saez RA, McGuire WL, Clark GM. Prognostic factors in breast cancer. Semin Surg Oncol 1989;5:102.
20. Sakorafas GH, Peros G, Cataliotti L. Sequelae following axillary lymph node dissection for breast cancer. Exp Rev Anticancer Ther 2006;6:1629.
21. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
22. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 1998;339:941.
23. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864.
24. Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the Breast, April 19-22, 2001, Philadelphia, PA. Cancer 2002;94:2542.
25. McCready D, Holloway C, Shelley W, et al., and the Breast Cancer Disease Site Group of Cancer Care; Ontario's Program in Evidence-Based Care. Surgical management of early stage invasive breast cancer: A practice guideline. Can J Surg 2005;48:185.
26. Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 1996;23:1588.
27. Adler LP, Faulhaber PF, Schnur KC, et al. Axillary lymph node metastases: screening with [F-18] 2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997;203:323.
28. Smith IC, Ogston KN, Whitford P, et al. Staging of the axilla in breast cancer: Accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg 1998;228:220.
29. Hubner KF, Smith GT, Thie JA, et al. The potential of F-18-FDG-PET in breast cancer: Detection of primary lesions, axillary lymph node metastases, or distant metastases. Clin Positron Imaging 2000;3:197.
30. Greco M, Crippa F, Agresti R, et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: Clinical evaluation and alternative management. J Natl Cancer Inst 2001;93:630.
31. Guller U, Nitzsche EU, Schirp U, et al. Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: Not yet! Breast Cancer Res Treat 2002;71:171.
32. van der Hoeven JJ, Hoekstra OS, Comans EF, et al. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg 2002;236:619.
33. Barranger E, Grahek D, Antoine M, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol 2003;10:622.
34. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG; PET Study Group. Prospective, multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the staging breast cancer with PET Study Group. J Clin Oncol 2004;22:277.
35. 99mTc-tetrofosmin pinhole SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging. Cancer Biother Radiopharm 2001;16:501.
36. 99mTc-tetrofosmin axillary pinhole SPECT (P-SPECT) imaging versus radioguided sentinel lymph node (RSLN) biopsy. Int J Mol Med 2004;14(Suppl. 1):76.